Mon-Fri 9:00-18:00 CET+39 095 7211344info@vitasanlabs.com

Family · Pharmaceutical analytical standards

Rapamycin

An immunosuppressant macrolide produced by the bacterium Streptomyces hygroscopicus, first isolated in 1972 and approved in 1999 to prevent rejection in organ transplantation. This family brings together the active ingredient, labelled standards and other impurities.

Did you know?The name comes from Rapa Nui, the native name of Easter Island: the bacterium that produces it was found in samples collected on the island.

RapamycinGo to the active ingredient →
RapamycinActive ingredientRapamycinCat. No. P-R016-001CAS 53123-88-9
Rapamycin-d3Isotopically labelledRapamycin-d3Cat. No. P-R016-002CAS 392711-19-2

Need a molecule you cannot find?

Custom synthesis of impurities, metabolites and labelled compounds, with the same characterisation level.